Research Informatics for Operations (RIO) specifically addresses the growing technological needs of the clinical trials research community. The office provides a collaborative, responsive, integrated and focused approach to all aspects of systems development and support. Areas of particular interest include the continued expansion of OnCore, enhanced integration with Epic and other DF/HCC member institution systems and clinical trials reporting for the Cancer Center Support Grant (CCSG). 

RIO News & Updates

  • October 22, 2019 – PRMS

    Subsites are currently not receiving activation emails for amendments. A solution for this is in development. For now, please check OncPro to see if the submission is active.

  • October 21, 2019 – PRMS

    All communication emails relating to a specific trial will be sent to the staff listed in iRIS under Study Contact. At time of new submission, the Overall PI will default to be listed as a study contact. If the PI has...

  • October 20, 2019 – PRMS

    Sub-site study status is not automatically updated when the lead site submits a status change amendment in iRIS. Sub-site status may also be an issue for migrated studies where an NPA or add site submission was submitted...

Issue Resolution

Patient Care Critical (PCC) Issues
If you have a patient care critical (PCC) issue that requires immediate assistance, please contact the Help Desk at: 617-632-3399.

Non-Urgent Issues
All non-urgent issues can be resolved by entering a Help Desk ticket via the Help Desk Portal and assigning the ticket to the appropriate assignment group.

OnCore - DFCI (for OnCore, Epic, RSH, Tx Arms)
InForm - DFCI (for eDC)
InfoEd - DFCI (for InfoEd, InfoEd Tech Transfer)
OncPro - PHS (for OncPro, OHRS Submit, COST)
caTissue - DFCI (for caTissue)

Our Partners

Research Informatics Operations partners with the institutions of Dana-Farber/Harvard Cancer Center. 

Dana-Farber/Harvard Cancer Center (DF/HCC), an NCI-designated comprehensive cancer center, was founded to integrate and build upon the collective talent and resources of the Harvard cancer research community. Five Boston academic medical institutions—Beth Israel Deaconess Medical Center, Boston Children’s Hospital, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Massachusetts General Hospital—and two Harvard Schools—the Harvard Medical School and the Harvard T.H. Chan School of Public Health—combined their scientific strengths to create a rich, collaborative environment that transcends institutional borders. DF/HCC is the powerful successor organization to the Dana-Farber Cancer Institute Comprehensive Cancer Center, one of the original cancer centers designated by the NCI in 1973. 

Partners eCare

Partners eCare is a Partners-wide initiative to implement the Epic electronic health record and administrative system by 2017.

Hide